Stapled Antimicrobial Peptides for Gram-Negative Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antimicrobial peptides face challenges such as structural instability, proteolytic lability, and nonspecific membrane toxicity, limiting their clinical translation for treating antibiotic-resistant bacterial infections, particularly in Gram-negative bacteria.
Innovation Solution
Development of stapled antimicrobial peptides (StAMPs) based on the Esculentin-1A sequence with hydrocarbon staples, which include specific amino acid substitutions and crosslinks to enhance antimicrobial activity, selectivity for Gram-negative bacteria, and reduced toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If linear AMPs are used to combat antibiotic-resistant bacteria, then antimicrobial activity is achieved, but structural instability and proteolytic lability occur
Solution Approach 1:
The patent combines natural amino acid sequences with synthetic hydrocarbon staple moieties to create hybrid stapled peptides. The hydrocarbon staples (e.g., ethynyl, cyclopropyl, or cyclobutyl groups) are covalently attached to specific amino acid residues within the AMP sequence, forming a composite structure that integrates the antimicrobial properties of natural peptides with the structural stability of synthetic crosslinks.
Solution Approach 2:
The patent systematically varies parameters including the type of hydrocarbon staple (ethynyl, cyclopropyl, cyclobutyl), the positions of stapling within the peptide sequence, and the length/composition of the amino acid sequence to optimize both structural stability and antimicrobial activity. This parameter optimization enables tuning of the peptide's conformational stability while preserving its biological function.
2Reliability
If linear AMPs are used to kill bacteria, then antimicrobial efficacy is achieved, but nonsspecific membrane toxicity increases
Solution Approach 1:
The hydrocarbon staples are placed at specific local positions within the AMP sequence to selectively enhance interactions with bacterial membrane components while avoiding nonspecific toxicity. The stapling pattern is optimized to maintain selectivity for bacterial versus mammalian membranes by preserving local structural features that recognize bacterial-specific targets.
3Stability of the object's composition
If all-hydrocarbon staples are inserted to enforce α-helical structure, then proteolytic resistance is improved, but variable antimicrobial activity and indiscriminate membrane lysis occur
Solution Approach 1:
The patent optimizes the number, position, and type of hydrocarbon staples to achieve the minimum required for proteolytic resistance while avoiding excessive stapling that causes nonspecific membrane lysis. The amino acid sequence is also optimized to maintain appropriate charge distribution and hydrophobicity for selective bacterial membrane targeting.
Data Source
AI summary
Provided are stapled antimicrobial peptides (i.e., StAMPs) and methods of using the same (e.g., for treating bacterial infections caused by Gram-negative bacteria). In certain embodiments, the stapled peptides are based on the amino acid sequence of the antimicrobial peptide Esculentin-1A but include certain modifications that have been found to confer advantageous properties (e.g., improved antimicrobial activity, selectivity for killing Gram-negative bacteria, and/or reduced toxicity). Also provided are unstapled peptides which can serve as synthetic precursors to the stapled peptides provided herein.